Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Shares Outstanding (Weighted Average) (2016 - 2025)

CV Sciences (CVSI) has disclosed Shares Outstanding (Weighted Average) for 14 consecutive years, with $184.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 1614.08% to $184.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $184.3 million through Dec 2025, up 1614.08% year-over-year, with the annual reading at $184.3 million for FY2025, 1614.08% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $184.3 million in Q4 2025 for CV Sciences, roughly flat from $184.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $184.3 million in Q2 2025 to a low of $10.8 million in Q2 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $111.2 million across 5 years, with a median of $135.4 million in 2022.
  • Biggest YoY gain for Shares Outstanding (Weighted Average) was 1614.08% in 2025; the steepest drop was 93.41% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $107.1 million in 2021, then grew by 28.88% to $138.0 million in 2022, then rose by 11.53% to $154.0 million in 2023, then plummeted by 93.02% to $10.8 million in 2024, then surged by 1614.08% to $184.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CVSI at $184.3 million in Q4 2025, $184.3 million in Q3 2025, and $184.3 million in Q2 2025.